NCT01424124View on ClinicalTrials.gov

Safety and Efficacy of YHD001 in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

January 31, 2014

Conditions
Asthma
Interventions
DRUG

YHD001 dose level 1

Tablet, three times daily / 8 weeks

DRUG

YHD001 dose level 2

Tablet, three times daily / 8 weeks

DRUG

Singulair

Tablet, one times daily / 8 weeks

DRUG

Placebo

Tablet, one times daily / 7 days

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01424124 - Safety and Efficacy of YHD001 in Asthma | Biotech Hunter | Biotech Hunter